- Home
- IOBT vs GDO Comparison
IOBT vs GDO Comparison
Compare IOBT & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- GDO
- Stock Information
- Founded
- IOBT 2014
- GDO 2009
- Country
- IOBT Denmark
- GDO United States
- Employees
- IOBT N/A
- GDO N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- GDO Finance Companies
- Sector
- IOBT Health Care
- GDO Finance
- Exchange
- IOBT Nasdaq
- GDO Nasdaq
- Market Cap
- IOBT 91.6M
- GDO 86.3M
- IPO Year
- IOBT 2021
- GDO N/A
- Fundamental
- Price
- IOBT $2.06
- GDO $11.72
- Analyst Decision
- IOBT Strong Buy
- GDO
- Analyst Count
- IOBT 3
- GDO 0
- Target Price
- IOBT $9.33
- GDO N/A
- AVG Volume (30 Days)
- IOBT 411.7K
- GDO 39.4K
- Earning Date
- IOBT 08-12-2025
- GDO 01-01-0001
- Dividend Yield
- IOBT N/A
- GDO 9.81%
- EPS Growth
- IOBT N/A
- GDO N/A
- EPS
- IOBT N/A
- GDO N/A
- Revenue
- IOBT N/A
- GDO N/A
- Revenue This Year
- IOBT N/A
- GDO N/A
- Revenue Next Year
- IOBT N/A
- GDO N/A
- P/E Ratio
- IOBT N/A
- GDO N/A
- Revenue Growth
- IOBT N/A
- GDO N/A
- 52 Week Low
- IOBT $0.66
- GDO $11.21
- 52 Week High
- IOBT $2.24
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- IOBT 73.49
- GDO 55.22
- Support Level
- IOBT $1.88
- GDO $11.64
- Resistance Level
- IOBT $2.15
- GDO $11.82
- Average True Range (ATR)
- IOBT 0.19
- GDO 0.10
- MACD
- IOBT 0.03
- GDO -0.01
- Stochastic Oscillator
- IOBT 80.00
- GDO 59.26
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.